Home/Novita Pharmaceuticals/Xin-Yun Huang

XH

Xin-Yun Huang

Co-Founder

Novita Pharmaceuticals

Therapeutic Areas

Oncology Infectious Diseases Neurological Degenerative Diseases

Novita Pharmaceuticals Pipeline

Drug	Indication	Phase
NP-G2-044	Advanced/Metastatic Solid Tumor Malignancies (Monotherapy)	Phase 2a
NP-G2-044 + anti-PD-1 Inhibitors	Solid Tumors	Phase 2a
NP-G2-044 + Chemotherapy Agents	Ovarian Cancer	Phase 2a

Leadership Team at Novita Pharmaceuticals

Stewart Campbell

Chief Executive Officer, Board Member

President, Chief Scientific Officer, Co-Founder, Board Director

Christy Y. Shue

Chief Financial Officer

View full Novita Pharmaceuticals profile